Review Article | Published:

Age-related changes in lymphocyte development and function

Nature Immunologyvolume 5pages133139 (2004) | Download Citation



The effects of aging on the immune system are widespread and extend from hematopoietic stem cells and lymphoid progenitors in the bone marrow and thymus to mature lymphocytes in secondary lymphoid organs. These changes combine to result in a diminution of immune responsiveness in the elderly. This review aims to provide an overview of age-related changes in lymphocyte development and function and discusses current controversies in the field of aging research.


Involution of the thymus and diminished output of T lymphocytes are arguably the most recognized changes in the immune system with age. However, it is increasingly evident that the effects of aging on the immune system are widespread, extending from hematopoietic stem cells and lymphoid progenitors to mature lymphocytes in secondary lymphoid organs. Together, the changes in these populations combine to cause a substantial diminution in immune responsiveness in the elderly.

Many of the age-related phenomena that affect the immune system have been recognized for some time. However, studies of how aging affects them are moving beyond description and are now focused on identifying the mechanisms responsible for changes in lymphocyte development and function during senescence. The ability to do so is directly related to our increased understanding of the molecular and cellular controls of these processes. The information obtained should be of practical relevance to increasing the efficacy of vaccination in the elderly and in restoring immunity in immunocompromised individuals. The aim of this review is to provide an overview of the current issues and controversies in the field.

Aging and hematopoietic stem cells

Hematopoietic stem cells (HSCs) are defined by their ability to proliferate and generate new HSCs as well as more differentiated progeny from which myeloid and lymphoid cells develop1. Because all lymphocytes are ultimately derived from HSCs, age-associated perturbations that affect lymphopoiesis could have a considerable effect on the immune system.

It is becoming increasingly apparent that the proliferative potential of HSCs and the size of the HSC compartment are under genetic control2, and genes that influence these properties have been mapped to several quantitative trait loci2,3,4,5,6. These genes could encode functions such as DNA repair or responsiveness to environmental signals2, and age-related changes in expression or activity of their products could in turn affect the quality of HSCs. The results of competitive repopulation studies, in which young and old cells from the same strain are mixed and transplanted into the same recipient, are particularly illustrative of this point: HSCs from old mice show a decreased repopulating efficiency compared with their young counterparts7, and this effect must be intrinsic, as these cells were competing in an identical hematopoietic microenvironment.

One explanation for these results is that the ability of HSCs to replicate decreases with age2. In addition, there is mounting evidence that aging may also affect HSC developmental potential. Blood cell production represents a balance between stem cell self-renewal and the production of daughter cells destined to generate myeloid or lymphoid progeny (Fig. 1). However, many studies have demonstrated that bone marrow or purified HSCs from old mice do not efficiently generate lymphoid progeny8,9,10,11. These findings are consistent with recent evidence that the frequency and number of bone marrow common lymphocyte progenitors (CLPs) are considerably reduced by 7 months of age12. Although the decrease in CLP number with age suggests that the diminished lymphopoietic potential of aged bone marrow is due to inefficient generation of normal numbers of lymphoid committed progeny, it is also possible that those lymphoid progenitors that are produced have defects in survival and/or proliferative potential. The degree to which decreases in lymphocyte production, compared with age-associated defects that accumulate in mature B and T cells (as described in subsequent sections here), contribute to decreased immunity with age remains to be determined.

Figure 1: Bone marrow from old mice does not efficiently generate lymphoid progeny.
Figure 1

(a) Bone marrow HSCs from young mice can self-renew and generate precursors from which myeloid and lymphoid cells are generated. In young individuals, there is a balance between these events. (b,c) It is not known why bone marrow cells from old donors are less efficient at generating lymphoid progeny. One possibility (b) is that old HSCs may produce fewer lymphoid progenitors. Another (c) is that they are produced in normal numbers but show decreased proliferation and/or survival with age. M, myeloid progenitors; L, lymphoid progenitors.

Little is known regarding how age-related perturbations in the hematopoietic microenvironment might affect HSC self-renewal and lineage commitment13,14. However, many studies have indicated that extramedullary changes with age, and those in the endocrine system in particular, may affect hematopoiesis. Decreases in the production of anterior pituitary–derived growth hormone occur with age15 and have been linked to the well-recognized phenomenon that within much of the skeletons of elderly individuals, hematopoiesis becomes quiescent with age and deposition of adipose tissue increases. Administration of growth hormone to old rats reverses this trend by replacing adipose tissue with active marrow and increasing hematopoiesis16. One explanation for this finding is that HSCs or their progeny are responsive to growth hormone, or growth hormone–induced mediators such as insulin-like growth factor I (IGF-I), and with age the combined effects of diminished hormone concentration and intrinsic HSC changes reduce the number of precursors capable of sustaining hematopoiesis in all bones. Consequently, adipose cells increase by default to fill the available space. Additionally, the function and/or maintenance of bone marrow stromal cells may be dependent on the growth hormone–IGF-I axis, and as concentrations decrease, stromal cells convert to adipocytes incapable of supporting hematopoiesis (Fig. 2). As will be emphasized throughout this review, these possibilities indicate that age-related changes in multiple systems may combine to affect the development and function of hematopoietic cells.

Figure 2: Primary lymphocyte development in the bone marrow and thymus.
Figure 2

The cellular stages of mouse B cell development in the bone marrow and T cell development in the thymus. Cells at distinct stages of development in each organ can be identified based on their expression of various cell surface determinants. Aging may result in the accumulation of developmental defects within lymphoid precursors and within supporting stromal cells that form the bone marrow and thymus microenvironments. Extramedullary and extrathymic changes that occur with age, and those in the endocrine system in particular may exacerbate decreases in lymphoid production. In particular, there is decreased production of growth hormone (GH) and IGF-I and an increase in the production of sex steroids with age. The growth hormone–IGF-I axis is thought to enhance lymphopoiesis, whereas sex steroids produced in the gonads have negative effects on B and T cell production. SLC, surrogate light chain.

Aging and primary B lymphocyte development

The bone marrow is the site of antigen-independent, primary B lymphocyte development. The most immature B lineage–committed cells are referred to as pro-B cells. If immunoglobulin heavy chain gene rearrangements are productive at this stage, pre-B cells develop in which immunoglobulin heavy chain protein of the μ class is expressed in the cytoplasm and at the surface in association with the surrogate light chains V-pre-B and λ5. Subsequently, immunoglobulin light chain genes rearrange and the surrogate light chains are replaced by κ or λ light chain protein. Cells at these stages of development can be identified based on expression of various cell surface determinants17 (Fig. 2).

Consistent with the approximately 90% reduction in CLP numbers in 20-month-old mice, the frequency and number of pro-B cells is also reduced substantially with age12. For example, the frequency of CD45R+CD43+CD19+AA4+ pro-B cells in 20-month-old male and 18-month-old female mice is reduced by 87% and 75%, respectively. This observation is not in accord with earlier studies indicating modest or no significant decreases in the pro-B cell compartment in old mice18,19. The reason for this discrepancy may be the strategies used to identify and count pro-B cells. Pro-B cells in the bone marrow are CD43+B220lo, and cells with this phenotype also include non-B lineage cells. The report concluding that there is a diminution in pro-B cell numbers with age excluded the latter cells from analysis12, whereas the other two reports analyzed the total CD43+B220+ population18,19.

The transition of pro-B cells into pre-B cells also decreases with age18,19,20 because of impaired V-DJ heavy chain gene recombination21. This decrease is not because of decreased amounts of recombination activation gene products, but could instead be related to changes in the expression and activity of the E2A-encoded E12 and E47 transcription factors22. E12 and E47 are basic helix-loop-helix proteins that bind to the immunoglobulin heavy chain enhancer, and their expression is required for immunoglobulin heavy chain expression. E2A family members also regulate the expression of surrogate light chains, which would explain the observation that pre-B cells from old mice show diminished expression of V-pre-B and λ5 (ref. 23). Whether downregulation of E2A expression is the event that triggers the decrease in B lymphopoiesis or is an epiphenomenon is unclear. Expression of immunoglobulin transgenes, which would bypass the above defects, does not compensate for poor B cell development24. Thus, mechanisms other than decreased E2A expression must be involved when decreases in primary B lymphopoiesis are found.

There is disagreement in the literature regarding the effects of aging on the number of surface immunoglobulin-positive cells in the bone marrow. One study made the unexpected observation that their number was relatively normal19, whereas another report indicated the immunoglobulin-positive B cell numbers were reduced18. Despite these differences, the consistent finding in both reports is that numbers of B cells were higher than would have been predicted, given the decreases in the pre-B cell compartment. Hypotheses to explain this finding include relaxation of the mechanisms that normally regulate the pre-B-to-B cell transition with age, increased lifespan of immature B cells and reduced migration of B cells from the bone marrow19.

The impaired generation of B cells in old mice reconstituted with young donor bone marrow cells and the inefficient secretion of interleukin 7 (IL-7) by stromal cells from old mice indicate that the B lymphopoietic support potential of the hematopoietic microenvironment decreases with age25,26. However, extrinsic effects alone cannot explain decreases in the number of B lineage cells with age, because pro-B cells exposed in vitro to nonlimiting amounts of IL-7 proliferate less than their young counterparts12,27. Pro-B cells from old mice express the IL-7 receptor α and common γ chains in normal amounts26, so age-related defects in IL-7 responsiveness might instead be due to aberrations in IL-7 signaling pathways. If this were the case, it could help to explain defects in V-DJ joining in pro-B cells, which is an IL-7-dependent event28. A similar interplay between microenvironmental and intrinsic changes in B cell progenitors could also affect human B lymphopoiesis. However, IL-7 does not have the same obligate function in humans that it has in mice29.

Despite the changes noted above, not all old mice show a severe decrease in B lymphopoiesis. This unexpected finding was demonstrated in a study of 50 old mice that demonstrated that half had pre-B cell numbers similar to those in young mice19. Because young and old mice from the same strain were analyzed, genetic effects alone cannot provide an explanation for this finding. Instead, these data make it necessary to consider that environmental factors are involved when decreases in B cell production are found in old mice. Mice within a colony are known to adopt a dominant or submissive posture, and assumption of either role may be stressful30. This in turn could stimulate an increase in production of steroid hormones in particular old mice. Because post-pubertal animals already have increased amounts of sex steroids15, which are known to suppress B lymphopoiesis31, the additive effects of these hormonal changes could exacerbate intrinsic changes that occur in B cell precursors and lead to more pronounced decreases in B cell production in selected subpopulations of animals. The effect of environmental factors may be of relevance when reconciling disparate data from different laboratories.

Aging and secondary B cell development

After their emigration from the bone marrow, newly produced B cells enter the spleen and progress through various transitional stages before maturing into follicular or marginal zone B cells. The continual entry of immature B cells into the spleen and selection into the follicular and marginal zone pools ensures a constant turnover of splenic B cells and maintenance of the B cell repertoire32 (Fig. 3).

Figure 3: Age-related changes in B and T cells in secondary lymphoid organs.
Figure 3

After their production in the bone marrow and thymus, lymphocytes home to particular sites within secondary lymphoid tissues such as the lymph nodes and spleen. With age, fewer mature B and T cells are produced and these may not emigrate efficiently from their tissue of origin. Additional age-related perturbations that occur in mature B and T cells in the periphery contribute to decreases in both humoral and cell-mediated immunity in the elderly. Yellow arrows: ↓, decrease; ↑, increase.

There is agreement that aging results in perturbations of peripheral B cells in two important ways. The number of newly made B cells that migrate to the spleen from the bone marrow is reduced. This reduction could be due to the inability of bone marrow B cells to respond to cues that stimulate their exit from the marrow and/or to the diminished production of those stimuli, and the resultant buildup of B cells in the marrow could explain why numbers are relatively normal in old mice18,19. In addition, there is an accumulation of B lineage cells in the splenic transitional and mature compartments that do not label with 5-bromodeoxyuridine, even after extended administration times18,19. Many of these latter cells are antigen-experienced memory B cells that have filled peripheral niches because of diminished production of follicular B cells24.

These changes in the composition of the peripheral B cell pool in turn have consequences for humoral immunity. For example, the duration of the humoral response in aged individuals is relatively shorter than it is in the young, and the immunoglobulins produced are less protective because of their low titer and affinity33,34,35,36. Furthermore, even though they are capable of isotype switching, the proportion of immunoglobulin M antibodies secreted by aged B cells is increased, and the V region genes used are distinct from those used by young adults37,38 (Fig. 3). Many of these effects may be a consequence of functional defects intrinsic to the B cells, including reduced expression of costimulatory molecules such as B7 (CD86)39 and defects in signaling through the B cell receptor40, but others may be secondary to age-related changes in CD4 T cells and the aged microenvironment. CD4 T cells are required for germinal center formation41 and the activation of somatic mutation genes42, so defects in T helper function with age may contribute to the diminished ability of aged individuals to produce a vigorous, high-affinity antibody response in the germinal center reaction39. Indeed, aged CD4 T cells are less efficient at inducing germinal center formation and promoting somatic hypermutation39,43.

The bone marrow is the main source of antibody-forming cells (AFCs) in both man and mouse44, and antigen-reactive B cells and AFCs in the bone marrow contain more somatic mutations and produce antibody with higher affinity than do their splenic counterparts45. Given that the presence of long-lived AFCs in the bone marrow is dependent on their production in germinal centers46, the finding of reduced numbers of high-affinity AFCs in the bone marrow of aged mice47 is not unexpected. However, additional age-related changes in the bone marrow microenvironment may also affect the ability of AFCs to undergo somatic hypermutation, selection and/or survival47.

Aging and primary T cell development

The thymus does not contain endogenous stem cells capable of unlimited self-renewal and must be 'seeded' periodically with bone marrow–derived precursors that could include HSCs and/or more differentiated HSC progeny. This process is highly regulated, and input of precursors into the thymus occurs only at distinct temporal 'windows'48. The most immature intrathymic, bone marrow–derived progenitors are included in the double-negative 1 (DN1) fraction, defined by its CD3CD4CD8CD44+CD25 phenotype49. These progenitors mature through various cellular stages before generating CD4 helper and CD8 cytotoxic T cells (Fig. 2).

Thymic involution has generally been considered to initiate at puberty, but atrophy of the epithelial space begins by 1 year of age in humans. By the time of middle age, most parenchymal tissue is replaced by fat, although functional thymic tissue remains in humans at least until the sixth decade of life50,51. In both mouse and man, fewer T cells are produced and exported to secondary lymphoid organs as aging progresses. This in turn has consequences for the maintenance of the naive repertoire in the peripheral T cell pool, as discussed below. Because thymic involution progresses more rapidly in some strains of mice, genetic factors undoubtedly underlie that process52.

As noted before, bone marrow cells or purified HSCs from old mice do not efficiently generate T cells after transfer into young recipients8,9,10,11, indicating that intrinsic defects that accumulate with age affect their developmental potential. However, current models of thymic involution propose that the frequency of DN1 thymocytes increases and their absolute number does not decrease with age. In addition, DN1 thymocytes from old mice are thought to have normal developmental potential, but their maturation is blocked because of defects in the thymic microenvironment53,54,55,56. Proposing that intrathymic T cell progenitors are developmentally normal is puzzling, if T lymphopoietic defects exist in bone marrow precursors. Some studies that have reported increased numbers of T cell progenitors in the aging thymus have based this conclusion on analysis of DN1 cells defined by a CD3CD4CD8CD44+CD25 phenotype. However, this fraction includes a high frequency of non-T lineage cells, with T cell progenitors constituting only a fraction of cells within it49. Two studies have localized T cell progenitor activity within the DN1 fraction to two subpopulations of cells called early T lineage progenitor57 and CLP-2 (ref. 58; Fig. 2). The precise developmental relationship between early T lineage progenitor and CLP-2 is unclear at this point, but a determination of how these two populations are affected by age may provide a more accurate picture of how aging affects the most immature intrathymic progenitors.

Even if such analyses show defects in the T cell progenitor pool, changes in the thymic microenvironment may nevertheless contribute to thymic involution59. That this is the case is supported by studies demonstrating that thymic involution is not reversed by administration of young bone marrow cells to old mice60 and that decreases in the expression of various epithelial cell genes that include IL-7 (ref. 61), keratin-8 and Foxn1 (ref. 62) occur with age. The challenge in this area is to determine the degree to which age-related decreases in the thymic microenvironment affect thymopoiesis and whether changes that do occur result from loss of particular thymic stromal cell types and/or changes in their function.

Any model proposing changes in T cell progenitors or thymic stromal cells alone as the cause of thymic involution may be too simplistic, particularly given studies demonstrating that these two compartments are developmentally and functionally symbiotic63,64,65,66. The thymic anlage is a third pharyngeal pouch derivative, and thymic epithelial cell precursors arise from its endoderm by thymocyte-independent mechanisms. However, maturation of these epithelial progenitors into cortical and medullary thymic stromal cells and the maintenance of these populations are T cell dependent66, and mice with T cell developmental defects have poorly developed and organized thymic stromal cells63,64,65,66. These findings indicate a working model in which age-related defects in both T cell progenitors and thymic stromal cells contribute to involution of the thymus. These changes could occur simultaneously in each compartment or one could precede the other. In either case, changes in one compartment with age could initiate a downward spiral of degenerative events that affect the other compartment. Even if thymic epithelial progenitor cells67 were present in the postnatal thymus and attempted to replenish the thymic stromal cell pool, their numbers might eventually be depleted.

This interplay between developing thymocytes and thymic stromal cells may be sensitive to changes in the endocrine system described above and in Figure 2. Both developing thymocytes as well as thymic stromal cells express receptors for one or more hormones that include growth hormone, IGF-I and sex steroids68,69. Growth hormone and IGF-I are generally considered to have antiapoptotic effects on thymocytes and to stimulate production of cytokines by thymic stromal cells. In contrast, increasing concentrations of steroids are thought to be toxic to developing thymocytes. Thus, changes in the relative concentrations of these hormones at puberty could negatively affect thymocyte development and/or thymic stromal cell function and exacerbate thymic involution. This seems to apply particularly in males, given reports that androgens accelerate thymic involution70 and orchiectomy can reverse, at least in part, that process71. Ovariectomized mice also have increased thymus size, although not to the same degree as do castrated males, indicating that the effects of estrogens on thymopoiesis may not be as deleterious as those of androgens71.

Many rodent studies have demonstrated that administration of growth hormone or IGF-I to old mice can stimulate thymopoiesis68,72, and these data have provided the rationale for clinical trials in which growth hormone administration increases thymus size in humans73. However, growth hormone or IGF-I administration to old mice does not restore thymus cellularity to the numbers found in young animals68, providing additional evidence that thymic involution is a multifactorial process. As with growth hormone, administration of IL-7 can also increase thymus cellularity in old mice59,74, but cellularity is not restored to match the numbers found in the young, indicating that decreases in its production are yet another, but not the only, factor contributing to thymic atrophy. Because it seems to be a multifactorial event, rejuvenation of the involuted thymus to the levels found in young animals may be difficult. The critical issue is whether increased thymopoiesis that results from a single intervention, such as growth hormone or IL-7 treatment, is sufficient to mitigate changes in the peripheral T cell pool described below.

Aging and secondary T cell development

After their production in the thymus, newly produced T cells migrate into distinct sites within secondary lymphoid organs. Splenic T cells are found in the periarteriolar lymphoid sheath (Fig. 3). Total T cell numbers in these sites and the CD4/CD8 ratio are relatively unaffected by aging.

Despite the maintenance of normal T cell numbers with age, there is a considerable decrease in CD4- and CD8-mediated responses75,76. For example, naive CD4 T cells in the aged secrete less IL-2, leading to decreased expression of CD25 (IL-2Rα), and show reduced proliferation and incomplete differentiation to T helper type 1 or type 2 effector cells77. In addition, CD4 memory T cells derived from aged naive precursors divide and produce cytokine poorly, whereas CD4 memory T cells derived from young mice function well into old age78. In CD8 T cells, the kinetics and magnitude of the overall antiviral response is reduced, resulting in delayed viral clearance79,80. This diminished cytolytic response seems to be due to a lower frequency of virus-specific CD8 cells, because on a per-cell basis CD8 activity remains unchanged79. Despite the lower frequency of virus-specific CD8 cells at the peak of the primary response, the frequency of those memory cells that are generated is maintained over time and their population expands in response to secondary viral exposure80. Because the magnitude of the initial response to immunization is the main determinant of the magnitude of subsequent responses81, these findings indicate that maintenance and restimulation of memory CD8 cells are normal in the aged.

One reason cell-mediated immunity decreases with age is the substantial reduction in the representation of naive T lymphocytes with a concomitant increase in memory T cells82. This shift in populations is thought to be the consequence of compensatory homeostatic proliferation in response to the reduced numbers of naive cells generated by the thymus as well as to the influence of cumulative exposure to foreign pathogens and environmental antigens. The effect of a reduction in naive T cells in the peripheral pool is the contraction of the T cell repertoire, which leads to an increased incidence of poor responsiveness to new antigens.

A second key change is that the activation potential of the memory T cells that accumulate is altered83,84, leading to hyporesponsivity82. These changes have been particularly well documented in CD4 T cells, for which studies of both humans and mice have documented changes in tyrosine- and serine/threonine-specific kinase activity, decreased ζ chain phosphorylation, decreased Raf-1/MEK/ERK kinase activation, decreased CD28-mediated JNK kinase activation, translocation of the transcription factor NFATc to the nucleus and decreased calcium flux after T cell receptor engagement or mitogen stimulation82,83,85. These signaling defects are not due to changes in the concentration of the T cell receptor–CD3 complex85. Instead, confocal microscopy has shown age-related alterations in the formation of the immunological synapse between CD4 T cells and antigen-presenting cells86. Specifically, there is a decrease in the proportion of aged T cells that successfully recruit a set of signal-transducing molecules such as PKC-θ, Vav and LAT to the supramolecular complex at the synaspe.

Finally, there is an increased, oligoclonal expansion of nontransformed T cell populations. Although clonal expansions of CD4 T cells can occur, CD8 T cell expansion is most prominent87,88. In most mice and in almost all humans over the age of 40, expanded clones of CD8 cells exist that are large enough to distort the αβ T cell repertoire89. In humans, these expanded cell populations seem to be resistant to apoptosis, lack expression of the CD28 costimulatory molecule and have shortened telomeres90. Although the etiology of clonally expanded populations is not thoroughly understood, evidence is accumulating that repeated viral infections drive the CD8 repertoire toward oligoclonality through either antigen-specific mechanisms or bystander proliferation in response to type 1 interferon91,92. Clearly, many of these effects are the result of intrinsic changes in T cells with age. A major challenge is to determine the degree to which the senescent environment contributes to decreases in cell-mediated immunity in the elderly.

Aging and the innate immune system

Studies of age-related effects on innate immunity are not as advanced as those of the adaptive immune system. In humoral immunity, an increase in marginal zone and B-1 B cell numbers with age has been reported20. B-1 B cells are thought to be a source of autoantibodies, and their increased number with age could explain the increased frequency of self-reactive immunoglobulins in the elderly24.

There is also evidence that monocytes and macrophages from aged mice show a reduced functional potential. Both splenic and activated peritoneal macrophages from aged mice express much lower amounts of Toll-like receptors and alterations in the secretion of various chemokines and cytokines that include IL-6 and tumor necrosis factor93,94. In addition, monocytes and macrophages from old mice have been shown to inhibit T cell proliferative responses95. Very little is known about dendritic cell changes with age, although their number in the epidermis decreases with age96,97.

Similarly, additional studies of natural killer (NK) cells are needed. There are indications that the number of NK cells increases with age, but on a per-cell basis their cytotoxic activity is diminished. The later decrease may be because of age-related changes in the protein kinase C–dependent pathway98. Aging mice also accumulate an NK-like CD8+ population of cells that are not present in young animals98.


As discussed above, a wide range of age-related changes in immune system development and function have been identified. However, a mechanistic understanding of these changes is still far from complete, and further analyses, particularly at the intracellular level, are needed. Some areas, such as the identification of epigenetic changes that might affect the aging immune system, are still in their infancy99.

A more complete understanding of the aging immune system has practical applicability. Although many of the changes that occur are subtle and may not be of much consequence to an individual in normal, steady-state conditions, they may become very relevant in conditions of stress. For example, even though HSC function decreases with age, such changes may not be noticeable until an individual is subjected to several rounds of chemotherapy that require HSC replication. Similarly, decreases in mature lymphocyte function may only be demonstrable in situations such as severe infection or vaccination100. As the size of the aging population increases, these issues will undoubtedly become more prominent.


  1. 1

    Kondo, M. et al. Biology of hematopoietic stem cells. Annu. Rev. Immunol. 21, 759–806 (2003).

  2. 2

    Geiger, H. & Van Zant, G. The aging of lympho-hematopoietic stem cells. Nat. Immunol. 3, 329–333 (2002).

  3. 3

    Henckaerts, E. et al. Genetically determined variation in the number of phenotypically defined hematopoietic progenitor and stem cells and in their response to early acting cytokines. Blood 99, 3947–3954 (2002).

  4. 4

    De Haan, G. et al. A genetic and genomic analysis identifies a cluster of genes associated with hematopoietic cell turnover. Blood 100, 2056–2062 (2002).

  5. 5

    Morrison, S.J. et al. A genetic determnant that specifically regulates the frequency of hematopoietic stem cells. J. Immunol. 168, 635–642 (2002).

  6. 6

    Morrison, S.J., Wandycz, A.M., Akashi, K., Globerson, A. & Weissman, I.L. 1996. The aging of hematopoietic stem cells. Nat. Med. 9, 1011–1016 (1996).

  7. 7

    Harrison, D. Long-term erythropoietic repopulating ability of old, young and fetal stem cells. J. Exp. Med. 157, 1496–1504 (1983).

  8. 8

    Tyan, M.L. Age-related decrease in mouse T cell progenitors. J. Immunol. 118, 846–851 (1977).

  9. 9

    Hirokawa, K., Kubo, S., Utsuyama, M., Kurashima, C. & Sado, T. Age-related change in the potential of bone marrow cells to repopulate the thymus and splenic T cells in mice. Cell. Immunol. 100, 443–451 (1986),

  10. 10

    Sharp, A., Kukulansky, T. & Globerson, A. In vitro analysis of age-related changes in the developmental potential of bone marrow thymocyte progenitors. Eur. J. Immunol. 20, 2541–2546 (1990).

  11. 11

    Sudo, K., Ema, H., Morita, Y. & Nakauchi, H. Age-associated characteristics of murine hemtopoietic stem cells. J. Exp. Med. 192, 1273–1280 (2000).

  12. 12

    Miller, J.P. & Allman, D. The decline in B lymphopoiesis in aged mice reflects loss of very early B-lineage precursors. J. Immunol. 171, 2326–2330 (2003).

  13. 13

    Chertkov, J.L. & Gurevitch, O.A. Age-related changes in hemopoietic microenvironment. Enhanced growth of hemopoietic stroma and weakened genetic resistance of hemopoietic cells in old mice. Exp. Gerontol. 16, 195–198 (1981).

  14. 14

    Hotta, T., Hirabayshi, N., Utsumi, M., Murate, T. & Yamada, H. Age related changes in the function of hemopoietic stroma in mice. Exp. Hematol. 8, 933–936 (1980).

  15. 15

    Lamberts, S.W.J., van den Beld, A.W. & van der Lely, A.-J. The endocrinology of aging. Science 278, 419–424 (1997).

  16. 16

    French, R.A. et al. Age-associated loss of bone marrow hematopoietic cells is reversed by GH and accompanies thymic reconstitution. Endocrinology 143, 690–699 (2002).

  17. 17

    Hardy, R.R. & Hayakawa, K. B cell development pathways. Annu. Rev. Immunol. 19, 595–621 (2001).

  18. 18

    Kline, G.H., Hayden, T.A. & Klinman, N.R. B cell maintenance in aged mice reflects both increased B cell longevity and decreased B cell generation. J. Immunol. 162, 3342–3349 (1999).

  19. 19

    Johnson, K.M., Owen, K. & Witte, P.L. Aging and developmental transitions in the B cell lineage. Int. Immunol. 14, 1313–1323 (2002).

  20. 20

    Cancro, M.P. & Smith, S.H. Peripheral B cell selection and homeostasis. Immunol. Res. 27, 141–148 (2003).

  21. 21

    Szabo, P., Shen, S., Telford, W. & Weksler, M.E. Impaired rearrangement of IgH V to DJ segments in bone marrow pro-B cells from old mice. Cell. Immunol. 222, 78–87 (2003).

  22. 22

    Frasca, D., Nguyen, D., Riley, R.L. & Blomberg, B.B. Decreased E12 and/orE47 transcription factor activity in the bone marrow as well as in the spleen of aged mice. J. Immunol. 170, 719–726 (2003).

  23. 23

    Sherwood, E.M., Xu, W., King, A.M., Blomberg, B.B. & Riley, R.L. The reduced expression of surrogate light chains in B cell precursors from senescent BALB/c mice is associated with decreased E2A proteins. Mech. Ageing Dev. 118, 45–59 (2000).

  24. 24

    Johnson, S.A., Rozzo, S.J. & Cambier, J.C. Aging-dependent exclusion of antigen- inexperienced cells from the peripheral B cell repertoire. J. Immunol. 168, 5014–5023 (2002).

  25. 25

    Li, F., Jin, F., Freitas, A., Szabo, P.l. & Weksler, M.E. Impaired regeneration of the peripheral B cell repertoire from bone marrow following lymphopenia. Eur. J. Immunol. 31, 500–505 (2001).

  26. 26

    Stephan, R.P., Reilly, C.R. & Witte, P.L. Impaired ability of bone marrow stromal cells to support B-lymphopoiesis with age. Blood 91, 75–88 (1998).

  27. 27

    Stephan, R.P., Lill-Elghanian, D.A. & Witte, P.L. Development of B cells in aged mice. Decline in the ability of pro-B cells to respond to IL-7 but not to other growth factors. J. Immunol. 158, 1598–1609 (1997).

  28. 28

    Corcoran, A.E., Riddell, A., Krooshoop, D. & Venkitaraman, A.R. Impaired immunoglobulin gene rearrangement in mice lacking the IL-7 receptor. Nature 391, 904–907 (1998).

  29. 29

    LeBien, T. Fate of human B-cell precursors. Blood 96, 9–23 (2000).

  30. 30

    Dorshkind, K. et al. Effects of housing on the thymic deficiency in dwarf mice and its reversal by growth hormone administration. Clin. Immunol. 109, 197–202 (2003).

  31. 31

    Kincade, P.W. et al. Early B-lymphocyte precursors and their regulation by sex steroids. Immunol. Rev. 175, 128–137 (2000).

  32. 32

    Chung, J.B., Silverman, M. & Monroe, J.G. Transitional B cells: step by step towards immune competence. Trends Immunol. 24, 342–348 (2003).

  33. 33

    Makinodan, T. & Kay, M.M. Age influence on the immune system. Adv. Immunol. 29, 287–330 (1980).

  34. 34

    Goidl, E.A., Innes, J.B. & Weksler, M.E. Immunological studies of aging. II. Loss of IgG and high avidity plaque-forming cells and increased suppressor cell activity in aging mice. J. Exp. Med. 144, 1037–1048 (1976).

  35. 35

    Zharhary, D., Segev, Y. & Gershon, H. The affinity and spectrum of cross reactivity of antibody production in senescent mice: the IgM response. Mech. Ageing Dev. 6, 385–392 (1977).

  36. 36

    Nicoletti, C., Yang, X. & Cerny, J. Repertoire diversity of antibody response to bacterial antigens in aged mice. III. Phosphorylcholine antibody from young and aged mice differ in structure and protective activity against infection with Streptococcus pneumoniae. J. Immunol. 150, 543–549 (1993).

  37. 37

    Riley, S.C. et al. Altered VH gene segment utilization in the response to phosphorylcholine by aged mice. J. Immunol. 143, 3798–805 (1989).

  38. 38

    Nicoletti, C. & Cerny, J. The repertoire diversity and magnitude of antibody responses to bacterial antigens in aged mice: I. Age-associated changes in antibody responses differ according to the mouse strain. Cell. Immunol. 133, 72–83 (1991).

  39. 39

    Zheng, B., Han, S., Takahashi, Y. & Kelsoe, G. Immunosenescence and germinal center reaction. Immunol. Rev. 160, 63–77 (1997).

  40. 40

    Whisler, R.L. & Grants, I.S. Age-related alterations in the activation and expression of phosphotyrosine kinases and protein kinase C (PKC) among human B cells. Mech. Ageing Dev. 71, 31–46 (1993).

  41. 41

    Jacobson, E.B., Caporale, L.H. & Thorbecke, G.J. Effect of thymus cell injections on germinal center formation in lymphoid tissues of nude (thymusless) mice. Cell. Immunol. 13, 416–430 (1974).

  42. 42

    Maizels, N. & Bothwell, A. The T-cell-independent immune response to the hapten NP uses a large repertoire of heavy chain genes. Cell 43, 715–720 (1985).

  43. 43

    Yang, X., Stedra, J. & Cerny, J. Relative contribution of T and B cells to hypermutation and selection of the antibody repertoire in germinal centers of aged mice. J. Exp. Med. 183, 959–970 (1996).

  44. 44

    Benner, R. & Haaijman, J.J. Aging of the lymphoid system at the organ level. With special reference to the bone marrow as site of antibody production. Dev. Comp. Immunol. 4, 591–603 (1980).

  45. 45

    Smith, K.G., Light, A., Nossal, G.J. & Tarlinton, D.M. The extent of affinity maturation differs between the memory and antibody-forming cell compartments in the primary immune response. EMBO J. 16, 2996–3006 (1997).

  46. 46

    Takahashi, Y., Dutta, P.R., Cerasoli, D.M. & Kelsoe, G. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. V. Affinity maturation develops in two stages of clonal selection. J. Exp. Med. 187, 885–895 (1998).

  47. 47

    Han, S. et al. Enhanced differentiation of splenic plasma cells but diminished long-lived high-affinity bone marrow plasma cells in aged mice. J. Immunol. 170, 1267–1273 (2003).

  48. 48

    Donskoy, E., Foss, D. & Goldschneider, I. Gated importation of prothymocytes by adult mouse thymus is coordinated with their periodic mobilization from bone marrow. J. Immunol. 171, 3568–3575 (2003).

  49. 49

    Ceredig, R. & Rolink, T. A positive look at double-negative thymocytes. Nat. Rev. Immunol. 2, 2–10 (2002).

  50. 50

    Haynes, B.F., Markert, M.L., Sempowski, G.D., Patel, D.D. & Hale, L.P. The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-I infection. Annu. Rev. Immunol. 18, 529–560 (2000).

  51. 51

    Jamieson, B.D. et al. Generation of functional thymocytes in the human adult. Immunity 10, 569–575 (1999).

  52. 52

    Hsu, H.C. et al. Age-related thymic involution in C57BL/6J x DBA/2J recombinant-inbred mice maps to chromosomes 9 and 10. Genes Immunol. 4, 402–410 (2003).

  53. 53

    Aspinall, R. Age-associated thymic atrophy in the mouse is due to a deficiency affecting rearrangement of the TCR during intrathymic T cell development. J. Immunol. 158, 3037–3045 (1997).

  54. 54

    Aspinall, R. & Andrew, D. Age-associated thymic atrophy is not associated with a deficiency in the CD44+CD25CD3CD4CD8 thymocyte population. Cell. Immunol. 212, 150–157 (2001).

  55. 55

    Thoman, M.L. The pattern of T lymphocyte differentiation is altered during thymic involution. Mech. Ageing Dev. 82, 155–170 (1995).

  56. 56

    Thoman, M.L. Early steps in T cell development are affected by aging. Cell. Immunol. 178, 117–123 (1997).

  57. 57

    Allman, D. et al. Thymopoiesis independent of common lymphoid progenitors. Nat. Immunol. 4, 168–174 (2003).

  58. 58

    Martin, C.H. et al. Efficient thymic immigration of B220+ lymphoid-restricted bone marrow cells with T precursor potential. Nat. Immunol. 4, 866–873 (2003).

  59. 59

    Aspinall, R. & Andrew, D. Thymic atrophy in the mouse is a soluble problem of the thymic environment. Vaccine 18, 1629–1637 (2000).

  60. 60

    Mackall, C.L., Punt, J.A., Morgan, P., Farr, A.G. & Gress, R.E. Thymic function in young/old chimeras: substantial thymic T cell regenerative capacity despite irreversible age-associated thymic involution. Eur. J. Immunol. 28, 1886–1893 (1998).

  61. 61

    Andrew, D. & Aspinall, R. Age-associated thymic atrophy is linked to a decline in IL-7 production. Exp. Gerontol. 37, 455–463 (2002).

  62. 62

    Ortman, C.L., Dittmar, K.A., Witte, P.L. & Le, P.T. Molecular characterization of the mouse involuted thymus: aberrations in expression of transcription regulators in thymocyte and epithelial compartments. Int. Immunol. 14, 813–822 (2002).

  63. 63

    Anderson, G. & Jenkinson, E.J. Lymphostromal interactions in thymic development and function. Nat. Rev. Immunol. 1, 31–40 (2001).

  64. 64

    Klug, D.B., Carter, C., Gimenez-Conti, I.B. & Richie, E.R. Thymocyte-independent and thymocyte dependent phases of epithelial patterning in fetal thymus. J. Immunol. 169, 2842–2845 (2002).

  65. 65

    Shores, E.W., Van Ewijk, W. & Singer, A. Maturation of medullary thymic epithelium requires thymocytes expressing fully assembled CD3-TCR complexes. Int. Immunol. 6, 1393–1402 (1994).

  66. 66

    Blackburn, C.C. et al. One for all and all for one: thymic epithelial stem cells and regeneration. Trends Immunol. 23, 391–395 (2002).

  67. 67

    Gill, J., Malin, M., Hollander, G.A. & Boyd, R. Generation of a complete thymic microenvironment by MTS24+ thymic epithelial cells. Nat. Immunol. 3, 635–642 (2002).

  68. 68

    Montecino-Rodriguez, E., Clark, R. & Dorshkind, K. Effects of insulin-like growth factor administration and bone marrow transplantation on thymopoiesis in aged mice. Endocrinology 139, 4120–4126 (1998).

  69. 69

    Savino, W. & Dardenne, M. Neuroendocrine control of thymus physiology. Endocrine Rev. 21, 412–443 (2000).

  70. 70

    Olsen, N.J., Viselli, S.M., Fan, J. & Kovacs, W.J. Androgens accelerate thymocyte apoptosis. Endocrinology 139, 748–752 (1998).

  71. 71

    Utsuyama, M. & Hirokawa, K. Hypertrophy of the thymus and restoration of immune functions in mice and rats by gonadectomy. Mech. Ageing Dev. 47, 175–185 (1989).

  72. 72

    Kelley, K.W. et al. GH3 pituitary adenoma cells can reverse thymic aging in rats. Proc. Natl. Acad. Sci. USA 85, 5663–5667 (1986).

  73. 73

    Napolitano, L.A. et al. Increased thymic mass and circulating naïve CD4 T cells in HIV-1 infected adults treated with growth hormone. AIDS 16, 1103–1111 (2002).

  74. 74

    Andrew, D. & Aspinall, R. IL-7 and not stem cell factor reverses both the increase in apoptosis and the decline in thymopoiesis seen in aged mice. J. Immunol. 166, 1524–1530 (2001).

  75. 75

    Effros, R.B., Cai, Z. & Linton, P.J. CD8 T cells and aging. Crit. Rev. Immunol. 23, 45–64 (2003).

  76. 76

    Grubeck-Loebenstein, B. & Wick, G. The aging of the immune system. Adv. Immunol. 80, 243–284 (2002).

  77. 77

    Linton, P.J., Haynes, L., Klinman, N.R. & Swain, S.L. Antigen-independent changes in naive CD4 T cells with aging. J. Exp. Med. 184, 1891–1900 (1996).

  78. 78

    Haynes, L., Eaton, S.M., Burns, E.M., Randall, T.D. & Swain, S.L. CD4 T cell memory derived from young naïve cells functions well into old age, while memory generated from aged naïve cells functions poorly. Proc. Natl. Acad. Sci. USA 100, 15053–15058 (2003).

  79. 79

    Po, J.L., Gardner, E.M., Anaraki, F., Katsikis, P.D. & Murasko, D.M. Age-associated decrease in virus-specific CD8+ T lymphocytes during primary influenza infection. Mech. Ageing Dev. 123, 1167–1181 (2002).

  80. 80

    Kapasi, Z.F., Murali-Krishna, K., McRae, M.L. & Ahmed, R. Defective generation but normal maintenance of memory T cells in old mice. Eur. J. Immunol. 32, 1567–1573 (2002).

  81. 81

    Murali-Krishna, K. et al. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8, 177–187 (1998).

  82. 82

    Lerner, A., Yamada, T. & Miller, R.A. Pgp-1hi T lymphocytes accumulate with age in mice and respond poorly to concanavalin A. Eur. J. Immunol. 19, 977–982 (1989).

  83. 83

    Miller, R.A., Garcia, G., Kirk, C.J. & Witkowski, J.M. Early activation defects in T lymphocytes from aged mice. Immunol. Rev. 160, 79–90 (1997).

  84. 84

    Nel, A.E. & Slaughter, N. T-cell activation through the antigen receptor. Part 2. A role of signaling cascades in T-cell differentitation, anergy, immune senescence, and development of immunotherapy. J. Allergy Clin. Immunol. 109, 901–915 (2002).

  85. 85

    Hirokawa, K. Age-related changes of signal transduction in T cells. Exp. Gerontol. 34, 7–18 (1999).

  86. 86

    Garcia, G.G. & Miller, R.A. Single-cell analyses reveal two defects in peptide-specific activation of naïve cells from aged mice. J. Immunol. 166, 3151–3157 (2001).

  87. 87

    Callahan, J.E., Kappler, J.W. & Marrack, P. Unexpected expansions of CD8-bearing cells in old mice. J. Immunol. 151, 6657–6669 (1993).

  88. 88

    Schwab, R. et al. Expanded CD4+ and CD8+ T cell clones in elderly humans. J. Immunol. 158, 4493–4499 (1997).

  89. 89

    Ku, C.C., Kotzin, B., Kappler, J. & Marrack, P. CD8+ T cell clones in old mice. Immunol. Rev. 160, 139–144 (2000).

  90. 90

    Effros, R.B. Long-term immunological memory against viruses. Mech. Ageing Dev. 121, 161–171 (2000).

  91. 91

    Khan, N. et al. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J. Immunol. 169, 1984–1992 (2002).

  92. 92

    Tough, D.F., Borrow, P. & Sprent, J. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 272, 1947–1950 (1996).

  93. 93

    Lloberas, J. & Celada, A. Effects of aging on macrophage function. Exp. Gerontol. 37, 1323–1329 (2003).

  94. 94

    Renshaw, M., Rockwell, J., Engleman, C., Gewirtz, A., Katz, J. & Sambhara, S. Impaired toll-like receptor expression and function in aging. J. Immunol. 169, 4697–4701 (2002).

  95. 95

    Pawelec, G., Solana, R., Remarque, E. & Mariani, E. Impact of aging on innate immunity. J. Leukoc. Biol. 64, 703–712 (1998).

  96. 96

    Uyemura, K., Castle, S.C. & Makinodan, T. The frail elderly: role of dendritic cells in the susceptibility of infection. Mech. Ageing Dev. 123, 955–962 (2002).

  97. 97

    Sprecher, E. et al. Effect of aging on epidermal dendritic cells populations in C57BL/6J mice. J. Invest. Dermatol. 94, 247–253 (1990).

  98. 98

    Solana, R. & Mariani, E. NK and NK/T cells in human senescence. Vaccine 18, 1613–1620 (2000).

  99. 99

    Issa, J.-P. Age-related epigenetic changes and the immune system. Clin. Immunol. 109, 103–108 (2003).

  100. 100

    Pinto, A., Fillippi, R., Friegeri, F., Corazelli, G. & Nomanno, N. Aging and the hemopoietic system. Crit. Rev. Oncol. Hematol. 48, S2–S12 (2003).

Download references


The continued support and encouragement of R. Fuldner from the National Institute of Aging is acknowledged. Supported by National Institutes of Health Grants AG21450 (K.D.), AG01743 (P.J.L.) and AG19249 (P.J.L.).

Author information


  1. Phyllis Jean Linton is at the Sidney Kimmel Cancer Center, San Diego, 92121, California, USA

    • Phyllis Jean Linton
  2. Department of Pathology and Laboratory Medicine and the Hematopoietic Malignancies Program, Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, 90095, California, USA

    • Kenneth Dorshkind


  1. Search for Phyllis Jean Linton in:

  2. Search for Kenneth Dorshkind in:

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Kenneth Dorshkind.

About this article

Publication history


Issue Date


Further reading